An antimineralocorticoid is currently recommended for patients with HFpEF who show elevated brain natriuretic peptide levels. Spironolactone is the first member of this medication class and the most frequently employed.[6] Care should be taken to monitor serum potassium levels as well as kidney function, specifically glomerular filtration rate during treatment.